Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aluminum-induced anemia.

L Kaiser, K A Schwartz

    American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Aluminum exposure causes microcytic hypoproliferative anemia, particularly in end-stage renal disease patients. Water treatment effectively reduces aluminum-related anemia, though its exact mechanism requires further study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Probing Instantaneous Single-Molecule Chirality in the Planar Ground State of Formic Acid.

    Physical review letters·2026
    Same author

    Selective Bond Breaking in CO_{2}^{2+} Induced by Photoelectron Recoil.

    Physical review letters·2025
    Same author

    Electron Diffraction Imaging of Carbon Monoxide via K-Shell Ionization by Compton Scattering of 20 keV Photons.

    Physical review letters·2025
    Same author

    Role of the Coulomb Potential in Compton Scattering.

    Physical review letters·2024
    Same author

    Role of the Binding Energy on Nondipole Effects in Single-Photon Ionization.

    Physical review letters·2024
    Same author

    CDK9 inhibition as an effective therapy for small cell lung cancer.

    Cell death & disease·2024
    Same journal

    Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
    Same journal

    Kidney Transplantation Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Multiple Myeloma.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
    Same journal

    Palliative Dialysis: Putting the Person First in Dialysis Care.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
    Same journal

    Associations of Pre-Pandemic CKD With Acute and Post-Acute COVID-19: The C4R Study.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
    Same journal

    Metabolic Acidosis and Progression of CKD: Current Guidelines and Considerations.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
    Same journal

    Pathophysiology of Ketoacidosis: Core Curriculum 2026.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Hematology
    • Toxicology

    Background:

    • Aluminum exposure is linked to anemia in end-stage renal disease (ESRD) patients.
    • Aluminum-induced anemia is characterized by microcytosis and hypoproliferation.
    • The precise mechanisms and interactions with other metals remain unclear.

    Purpose of the Study:

    • To elucidate the role of aluminum in anemia among ESRD patients.
    • To investigate the underlying mechanisms of aluminum-induced anemia.
    • To evaluate current and potential treatments for aluminum-related anemia.

    Main Methods:

    • Review of existing literature on aluminum toxicity and anemia.
    • Analysis of time-course studies in animal models (rat model mentioned).
    • Discussion of clinical observations in ESRD patients.

    Related Experiment Videos

    Main Results:

    • Aluminum is a confirmed cause of microcytic hypoproliferative anemia in ESRD.
    • Anemia in rats is preceded by microcytosis; human data is pending.
    • Potential mechanisms involve inhibition of heme synthesis and iron utilization.

    Conclusions:

    • Aluminum in dialysate poses clinical risks, including anemia, which can be mitigated by water treatment.
    • Removal of aluminum sources is a primary treatment, with desferrioxamine showing promise.
    • Further research is needed to understand aluminum's exact impact on heme synthesis, metal interactions, and treatment efficacy.